SISRAM MED (01696) announced its annual results for the year ended December 31, 2025. The group recorded revenue of $365 million, representing a 4.7% increase compared to the previous year. Profit attributable to owners of the parent company was $19.016 million, down 24.32% year-on-year. Basic earnings per share stood at 4.06 U.S. cents. The company proposed a final dividend of HK$0.095 per share.